Location History:
- Oppem, BE (1995)
- Weezenbeek-Oppem, BE (1996)
- Wezenbeek-Oppem, BE (1996)
- Wezembeek-Oppem, BE (2002)
Company Filing History:
Years Active: 1995-2002
Title: Innovations by Marcel Gielen
Introduction
Marcel Gielen is a notable inventor based in Wezembeek-Oppem, Belgium. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential therapeutic applications. With a total of four patents to his name, Gielen's work is recognized for its innovative approach to addressing complex medical challenges.
Latest Patents
Gielen's latest patents include "Tin polyoxaalkanecarboxylates and compositions containing them," which describes tin polyalkanecarboxylates exhibiting anti-tumor activity. The formula involves various alkyl groups and carboxylic residues, showcasing a sophisticated understanding of chemical interactions. Another significant patent is for "Dibutyltin bis(dihydroxybenzoates) and compositions containing these," which presents novel tin compounds that demonstrate excellent activity against various tumors. This invention also includes pharmaceutical compositions suitable for injection, highlighting Gielen's commitment to practical applications of his research.
Career Highlights
Throughout his career, Marcel Gielen has been associated with Pharmachemie B.V., where he has contributed to the advancement of pharmaceutical chemistry. His work has not only led to the development of innovative compounds but has also paved the way for new treatment options in oncology.
Collaborations
Gielen has collaborated with notable colleagues such as Rudolph Willem and Dick De Vos. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Marcel Gielen's contributions to the field of chemistry and pharmaceuticals are significant, with a focus on developing innovative compounds for medical use. His patents reflect a deep understanding of chemical properties and their applications in treating diseases. Gielen's work continues to inspire advancements in the pharmaceutical industry.